FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Factor patents



      
           
This page is updated frequently with new Factor-related patent applications. Subscribe to the Factor RSS feed to automatically get the update: related Factor RSS feeds. RSS updates for this page: Factor RSS RSS


Date/App# patent app List of recent Factor-related patents
12/11/14
20140365009
 Systems and methods for sensing objects patent thumbnailSystems and methods for sensing objects
Disclosed is a tactile sensing and integrated vision system that surmounts problems of existing systems. The tactile sensing skin can be formed into any shape, size, or form factor, including large areas.
12/11/14
20140364468
 Method for treating obesity patent thumbnailMethod for treating obesity
The present invention relates generally to methods of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight loss-promoting anti-convulsant either alone or in combination with bupropion or metabolites thereof or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.. .
12/11/14
20140364419
 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha patent thumbnailMethods for increasing the stabilization of hypoxia inducible factor-1 alpha
Disclosed herein are methods for controlling the activity of hypoxia-inducible transcription factor 1-alpha (hif-1α) and diseases, conditions, or syndromes related thereto, inter alia, peripheral vascular disease (pvd), coronary artery disease (cad), heart failure, ischemia, and anemia. Further disclosed are pharmaceutical compositions comprising hif-1α prolyl hydroxylase inhibitors useful in treating diseases, conditions, and/or syndromes related thereto the activity of hif-1α..
12/11/14
20140364369
 Use of chemically modified heparin derivates in sickle cell disease patent thumbnailUse of chemically modified heparin derivates in sickle cell disease
The present invention relates to chemically modified heparin for use in the treatment of sickle cell disease, with an antifactor ii activity of less than 10 iu/mg, an antifactor xa activity of less than 10 iu/mg and an average molecular weight (mw) between about 6.5 and 9.5 kda.. .
12/11/14
20140364330
 Multiplexed olfactory receptor-based microsurface plasmon polariton detector patent thumbnailMultiplexed olfactory receptor-based microsurface plasmon polariton detector
The invention provides a bio-sensing nanodevice comprising: a stabilized g-protein coupled receptor on a support, a real time receptor-ligand binding detection method, a test composition delivery system and a test composition recognition program. The g-protein coupled receptor can be stabilized using surfactant peptide.
12/11/14
20140363888
 Method for inducing differentiation of human pluripotent stem cells into intermediate mesoderm cells patent thumbnailMethod for inducing differentiation of human pluripotent stem cells into intermediate mesoderm cells
The present invention provides a method for inducing differentiation of a human pluripotent stem cell into an intermediate mesoderm cell without the use of a growth factor. Such method comprises performing culture in a medium containing a specific compound, so as to induce differentiation of a human pluripotent stem cell into an intermediate mesoderm cell..
12/11/14
20140363834
 Methods and compositions for diagnosis and prognosis of renal injury and renal failure patent thumbnailMethods and compositions for diagnosis and prognosis of renal injury and renal failure
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of growth/differentiation factor 2, catalase, vascular endothelial growth factor c, and melanoma-derived growth regulatory protein as diagnostic and prognostic biomarkers in renal injuries..
12/11/14
20140363818
 Egfr and par2 regulation of intestinal permeability patent thumbnailEgfr and par2 regulation of intestinal permeability
The present invention provides methods for diagnosing an immune-mediated disease, e.g., an autoimmune disease, an allergy or an inflammatory disease. Diagnosis is made by detecting a heterozygous or homozygous genotype of haptoglobin 2 or by detecting and quantifying pre-haptoglobin 2 mrna or protein.
12/11/14
20140363517
 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders patent thumbnailMethods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain.
12/11/14
20140363448
 Cdcp1 and breast cancer patent thumbnailCdcp1 and breast cancer
The present invention relates to a method for treating breast cancer in a subject having a hyperactivation of the epidermal growth factor receptor 1 and/or 2 (egfr and/or erbb2 her2), as compared to the normal subject population, or expressing deltaher2, which method comprises the step of administering to said subject a therapeutically effective amount of a modulator of the cub domain-containing protein 1 (cdcp1).. .
12/11/14
20140363445
Method of treating cancer comprising a vegf-b antagonist
The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue.
12/11/14
20140363432
Vascular endothelial cell growth factor antagonists and uses thereof
The present invention provides vascular endothelial cell growth factor (vegf) antagonists and methods of using vegf antagonists. Vegf antagonists contemplated by the invention include vegf antibodies and vegf receptor fusion proteins.
12/11/14
20140363419
Short-acting factor vii polypeptides
Short-acting factor vii peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders.
12/11/14
20140363403
Apparatus for harvesting improved bone graft material utilizing an implantable biodegradable filter
The present invention provides for the harvesting of specific materials in multiple stages of filtration of bone graft materials from a reaming device, specifics of interconnected stages, related filtration materials, and techniques. The harvesting process collects large material in a first stage, and other materials of a limited geometric size in at least a second stage of filtration.
12/11/14
20140362951
Crest factor reduction of carrier aggregated signals
The present disclosure advantageously provides methods and systems for crest factor reduction of multi-standard carrier aggregated signals. In one embodiment, a method of providing crest factor reduction for a carrier aggregated signal is provided.
12/11/14
20140362950
Crest factor reduction of inter-band carrier aggregated signals
A method, system and circuit for crest factor reduction of inter-band multi-standard carrier aggregated signals are disclosed. In one embodiment, a method includes calculating the amplitude of each of the plurality of carrier signals of the inter-band carrier aggregated signals.
12/11/14
20140362553
Three-dimensional form factor supporting high-speed signal processing systems
A reconfigurable advanced rapid-prototyping environment (rare) solution provides a three-dimensional (x, y, z) interconnection fabric that is a modular, reconfigurable, fully scalable high performance computing architecture. Rare allows processing nodes (modules) to communicate with other processing nodes (modules) in a three-dimensional mesh architecture where every processing node (module) has access to all other nodes (modules) in the system.
12/11/14
20140362523
Computer thermal management
The present application describes various embodiments regarding systems and methods for providing efficient heat rejection for a lightweight and durable compact computing system having a small form factor. The compact computing system can take the form of a desktop computer.
12/11/14
20140362522
Computer thermal system
The present application describes various embodiments regarding systems and methods for providing efficient heat rejection for a lightweight and durable compact computing system having a small form factor. The compact computing system can take the form of a desktop computer.
12/11/14
20140362366
Method and system for gas flow mitigation of molecular contamination of optics
A computer-implemented method for determining an optimized purge gas flow in a semi-conductor inspection metrology or lithography apparatus, comprising receiving a permissible contaminant mole fraction, a contaminant outgassing flow rate associated with a contaminant, a contaminant mass diffusivity, an outgassing surface length, a pressure, a temperature, a channel height, and a molecular weight of a purge gas, calculating a flow factor based on the permissible contaminant mole fraction, the contaminant outgassing flow rate, the channel height, and the outgassing surface length, comparing the flow factor to a predefined maximum flow factor value, calculating a minimum purge gas velocity and a purge gas mass flow rate from the flow factor, the contaminant mass diffusivity, the pressure, the temperature, and the molecular weight of the purge gas, and introducing the purge gas into the semi-conductor inspection metrology or lithography apparatus with the minimum purge gas velocity and the purge gas flow rate.. .
12/11/14
20140360127
Method for feed through construction
A method for creating a feed through construction barrier comprised of a collar defining the form factor of the barrier and a plurality of slidably connected and nested rods creating a continuous barrier conforming to the form factor of the collar. While the collar defines the form factor of the barrier, the slidable rods can be adjusted in their relative positions along the form factor to provide for a barrier that conforms to the contours of the application surface.
12/04/14
20140358777
Method for secure atm transactions using a portable device
The application provides a transaction-processing system for performing multi-factor verification of transactions between a plurality of users and a verification processor. The processor is in operational communication with a database storing a plurality of verification records, wherein each record comprises a unique id and said record containing at least one msisdn value.
12/04/14
20140358423
Method and apparatus for automatically warning driver to take a break
A driver caution threshold that varies by time of day and/or by driver activity load factor is compared a vehicle driver's activity. Responsive to a determination that vehicle driver's activity violates the driver caution threshold, a prompt to take a break and/or directions to a nearby restaurant are presented..
12/04/14
20140357731
Healing cream
A method for formulating a cationic and non-ionic oil in water emulsion, preferably in a cream form, containing growth factors, preferably platelet derived growth factors, specific matrikine peptides, botanicals, emollients, nano-molecules, antioxidants, antiseptics, neuro-peptides, anti-dermatophytics, polysaccharides, sensorial peptides, osmotically driven moisturizers, and siloxane barriers. For application to the feet and other affected parts of the body for the relief of diabetic skin and tissue trauma..
12/04/14
20140357720
Novel phytosphingosine derivatives, and a cosmetic composition comprising the same for preventing and ameliorating inflammatory skin diseases and hyperkeratosis diseases
A phytosphingosine derivatives of chemical formula ia or ib, and a cosmetic composition including the phytosphingosine derivative. The phytosphingosine derivatives are involved with transcription factors related to inflammation and hyperkeratotic diseases, the expression and the generation of inflammatory mediators, signal transduction mechanisms, and the expression and the activity of relevant enzymes and the like..
12/04/14
20140357696
Rnai-related inhibition of tnf alpha signaling pathway for treatment of ocular angiogenesis
Rna interference is provided for inhibition of tumor necrosis factor α (tnfα) by silencing tnfα cell surface receptor tnf receptor-1 (tnfr1) mrna expression, or by silencing tnfα converting enzyme (tace/adam17) mrna expression. Silencing such tnfα targets, in particular, is useful for treating patients having a tnfα-related condition or at risk of developing a tnfα-related condition, such as ocular angiogenesis, retinal ischemia, and diabetic retinopathy..
12/04/14
20140357694
Rnai-mediated inhibition of tumor necrosis factor alpha-related conditions
Rna interference is provided for inhibition of tumor necrosis factor α (tnfα) by silencing tnfα cell surface receptor tnf receptor-1 (tnfr1) mrna expression, or by silencing tnfα converting enzyme (tace/adam17) mrna expression. Silencing such tnfα targets, in particular, is useful for treating patients having a tnfα-related condition or at risk of developing a tnfα-related condition such as the ocular conditions dry eye, allergic conjunctivitis, or ocular inflammation, or such as dermatitis, rhinitis, or asthma, for example..
12/04/14
20140357613
Aminoheteroaryl compounds and preparation method and use thereof
The present invention refers to aminoheteroaryl compounds of the following formula (i) as well as the preparation method and use thereof, wherein r1 and r3 are defined in the description in details. The aminoheteroaryl compounds of the present invention are inhibitors of hepatocyte growth factor receptor (c-met), have favorable inhibitory effect against c-met and inhibitory effect against the proliferation of cancer cells, such that they may be used as therapeutic agents for the treatment of tumors and related diseases..
12/04/14
20140357565
Method of producing factor viii proteins by recombinant methods
Provided herein are methods and compositions for producing factor viii proteins. Such methods include introducing into a cell a nucleic acid molecule encoding a factor viii protein operably linked to a promoter, wherein the promoter is characterized by the ability to produce commercially viable factor viii protein; and incubating the cell under conditions for producing commercially viable factor viii protein.
12/04/14
20140357564
Von willebrand factor variants having improved factor viii binding affinity
The present invention relates to a polypeptide comprising a modified von willebrand factor (vwf) having a higher factor viii binding affinity than non-modified vwf, its pharmaceutical use and method of its preparation.. .
12/04/14
20140357517
Radiation exposure diagnostic marker igfbp-5, composition for radiation exposure diagnosis by measuring the expression level of the marker, radiation exposure diagnostic kit comprising the composition, and method for diagnosing radiation exposure using the marker
The present disclosure provides a composition for radiation exposure diagnosis including an agent for measuring an expression level of an insulin-like growth factor-binding protein-5 (igfbp-5) gene at an mrna or the protein and a kit for radiation exposure diagnosis. Methods of diagnosing radiation exposure as well as methods for screening an agent for enhancing radiation sensitivity or for radiation protection are disclosed.
12/04/14
20140357361
Apparatus, method and article to monitor gameplay using augmented reality
A portable computing system acquires images representative of a gaming environment (e.g., a gaming table and game participants) and provides augmented reality images including player personal and financial information and/or game or employee related information. The portable computing system can include a tablet form factor computing system having a touchscreen display.
12/04/14
20140357154
Device which uses air to produce olfactory auditory convergence and method of use
A device which uses air to produce olfactory auditory convergence includes a compressible body which has an internal cavity which contains the air. A noise making mechanism is connected to the compressible body.
12/04/14
20140356943
Reprogrammation of eukaryotic cells with engineered microvesicles
The present invention relates to a non-genetic, detergent-free, bacteria-free method for reprogramming a eukaryotic cell, in particular for obtaining induced pluripotent stem cells (ips), by using engineered microvesicles carrying at least one reprogramming transcription factor, wherein said engineered microvesicles are virus-free.. .
12/04/14
20140356346
Modified coagulation factor viia with extended half-life
The present invention relates to the fields of factor vii (fvii) and factor viia (fviia) albumin linked polypeptides. More specifically, the invention relates to cdna sequences coding for human factor vii and factor viia and derivatives genetically fused to a cdna coding for human serum albumin which may be linked by oligonucleotides which code for intervening peptidic linkers such encoded derivatives exhibiting improved stability and extended functional plasma half-life, recombinant expression vectors containing such cdna sequences, host cells transformed with such recombinant expression vectors, recombinant polypeptides and derivatives which do have biological activities of the unmodified wild type protein but having improved stability and prolonged shelf-life and processes for the manufacture of such recombinant proteins and their derivatives.
12/04/14
20140356321
Materials and methods for treatment of liver cancer
Granulin-epithelin precursor (gep), a pluripotent growth factor, is a hepatic oncofetal protein defining a cancer stem cell (csc) population in liver cancer. The present invention provides the use of gep inhibitors (including anti-gep antibody) for inhibiting immune evasion by liver cancer cells and for eliminating liver cancer stem cells..
12/04/14
20140356286
Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrin
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization..
12/04/14
20140355846
Fingerprint sensing apparatus
The light refracting device can, for example, be a tft light panel structure or an active matrix organic light emitting diode (amoled) panel structure with reverse current measurement and amplification circuitry, and includes an imaging surface and a viewing plane. Incident light from the light source is projected directly or indirectly onto the imaging surface to create an image of the patterned object from the projected light onto the viewing plane.
12/04/14
20140355308
Overnight power adapter
Techniques and devices related to power adapters for mobile devices and, in particular, small form factor power adapters that allow a voltage droop during a power pulse exceeding a maximum output of the power adapter are discussed. For example, a small form factor and low voltage power adapter may include an adapter output power protection control that limits an output of the power adapter in response to a power pulse exceeding a maximum output of the power adapter..
12/04/14
20140353390
Enhanced integrated circuit with smartcard controller
An rfid card includes a smartcard controller that receives power from a host device. The rfid card also includes a small inductive device capable of inductive coupling with an rfid reader.
11/27/14
20140351999
Nucleic acid molecules and other molecules associated with transcription in plants
The present invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding transcription factors, transcription factors, antibodies to transcription factors as well as plants and other organisms expressing transcription factors.
11/27/14
20140351963
Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositions and methods
Disclosed are compositions, such as nucleic acids, vectors, cells, animal models and the like, useful to reduce tumor growth, cancer cell migration and various other cancer pathologies associated with egfr (epidermal growth factor receptor) and met (the receptor tyrosine kinase for hepatocyte growth factors) dyregulation, particularly in non-small cell lung carcinoma.. .
11/27/14
20140351909
Authentication risk evaluation
A computer is configured to receive an authentication request that identifies one or more authentication form factors, and for each form factor identified, further identifies at least one parameter. The computer is further configured to generate a risk score for the authentication request using the parameter, the risk score being based at least in part on a complexity associated with each of the one or more authentication form factors.
11/27/14
20140351788
Renaming instances of an entity in a coding environment
Exemplary embodiments provide computer-implemented methods, computer-readable media, and systems for changing the identifier associated with an entity, such as a variable or function, in a portion of code. During editing, a reference may be maintained that identifies the location of each instance of the entity in the code.
11/27/14
20140350998
Project risk patterns modeling and risk mitigation
Project risk patterns modeling and risk mitigation. The method includes obtaining potential risk factors associated with a project.
11/27/14
20140350970
Computer system for determining geographic-location associated conditions
Pursuant to some embodiments, computer systems for generating safety scores relating to vehicle travel routes are provided which include a data storage device for storing, updating and providing access to loss risk score data. In some embodiments, a request for information associated with a user's location identified by user location data may be received over a communications network.
11/27/14
20140350957
Method and system for reducing early readmission
The exemplary embodiments are related to systems and methods for reducing early readmission according to an exemplary embodiment described herein. One embodiment relates to a method comprising receiving patient data for a patient; creating a personalized risk model for the patient based on the patient data, the personalized risk model including an overall risk level based on a plurality of risk factors; selecting one of the risk factors; administering treatment relating to the selected risk factor; updating the personalized risk model after administering treatment, the updating including determining an updated risk level; determining whether the updated risk level is above a threshold level; and repeating the selecting, administering, updating and determining steps if the risk level is above the threshold level..
11/27/14
20140350226
Rspondins as modulators of angiogenesis and vasculogenesis
The present invention relates to the use of rspondins, particularly rspondin2 (rspo2) or rspondin3 (rspo3) or rspondin nucleic acids, or regulators or effectors or modulators of rspondin, e.g. Rspo2 and/or rspo3 to promote or inhibit angiogenesis and/or vasculogenesis, respectively.
11/27/14
20140350037
Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
The present invention relates to a regimen for the administration of a pyrimidylaminobenzamide of formula i as defined herein for the treatment of proliferative disorders, particularly solid and liquid tumors, and other pathological conditions mediated by the bcr-abl oncoprotein, the cell transmembrane tyrosine kinase receptor c-kit, ddr1 (discoidin domain receptor 1), ddr2 (discoidin domain receptor 2) or pdgf-r (platelet derived growth factor receptor) kinase activity.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Factor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Factor with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.2494

3659

5 - 0 - 72